For readers interested in next-generation GLP-1-based drugs such as Lilly's oral candidate orforglipron, here's a comprehensive review from @DanielJDrucker
https://t.co/pM3Xc3F4u0
https://t.co/X714Dj2BNb
📊 New 4-Year Study: mRNA COVID Vaccines & Mortality
A 2025 JAMA Network Open study followed 28 million French adults (18–59) for almost 4 years. Key takeaway:
👉 No increased long-term mortality from mRNA COVID vaccines.
In fact, vaccinated adults had a 25% lower risk of death from any cause compared to unvaccinated adults, after adjusting for age, sex, socioeconomic status, and 41 comorbidities.
Other findings:
🔹74% lower risk of death from severe COVID-19 in vaccinated individuals.
🔹Lower mortality across major causes (cancer, cardiovascular disease, external causes).
🔹Short-term mortality was 29% lower within 6 months of vaccination.
📌 Bottom line:
Four years of national-level data show no signal of excess mortality—and suggest long-term safety of mRNA vaccines.
https://t.co/ISAXaWUD9D
Interesting interim (12 wk) data from Wave. The fat loss data are impressive but there isn't a major decrease in body weight or LM increase (expected). Looking forward to the '26 updates with the 600mg dose and longer follow up to see how the data evolve
https://t.co/fnm8K5doOa
#COVID19 South Korea encouraging sign continues again
-Daily new case# declines 5 days in a row
518➡️483➡️367➡️248➡️131
-Total cases: 7382➡️7513
-Deaths: 51➡️54
Many appear to take comfort in SK's trajectory. Just remember it only happened w/ broad testing + strong mitigation
This is fascinating!
Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
https://t.co/Y8tC0cRsEU
How intracranially injected CAR T cells invaded deeply into the solid tumor, reduced tumor growth, induced regression of CNS lymphoma
The first wave of KRAS G12C inhibitors are in the clinic--my long read on how chemists finally cracked this tough cancer target & what that work may (or may not) teach us about drugging the other RAS mutants: https://t.co/ft08cGSBAs